TCBIO
TEXAS CAPITAL BANCSHARES INC/TX
NASDAQ · Financial Services · Banks - Regional · US
$18.28
+0.00%Year over year
Reported trailing growth
- Revenue
- +13.5%
- EBITDA
- +149.4%
- EBIT
- +170.5%
- EPS
- +206.3%
- Free cash flow
- +28.9%
- Operating cash flow
- +17.5%
Forward estimates
Based on analyst estimates
- Revenue
- -31.3%
- EBITDA
- -9.4%
- EPS
- +1.9%
Three-year CAGR
- Revenue
- +19.9%
- EBITDA
- +0.5%
- EBIT
- +5.4%
- Net income
- -0.2%
- EPS
- +3.2%
- Free cash flow
- +37.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026